{"id":"W4408942933","doi":"10.6004/jnccn.2024.7252","title":"TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Immunotherapy; Oncology; Endometrial cancer; Internal medicine; Randomized controlled trial; Carcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002099716,0.001142983,0.002099126,0.000362793,0.0003261527,0.0009950205,0.0008195672,0.001726612,0.006094141],"category_scores_gemma":[0.002107318,0.0005354601,0.002346189,0.0003986706,0.0008687108,0.0006717143,0.0003861013,0.002618114,0.0006883764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011695,"about_ca_system_score_gemma":0.001259634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001700066,"about_ca_topic_score_gemma":0.003696439,"domain_scores_codex":[0.9990521,0.0005860861,0.00004076539,0.0001275452,0.00006860276,0.0001249378],"domain_scores_gemma":[0.9988689,0.000350128,0.0002909837,0.00007167448,0.00004761713,0.0003706175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859446,0.00231762,0.0006994024,0.0002317495,0.001270052,0.00004065989,0.00001321849,0.0003578516,0.0008826199,0.00008419833,0.00105909,0.00709883],"study_design_scores_gemma":[0.9576568,0.03764863,0.002204692,0.00002805585,0.001000508,0.00002379142,0.00001278122,0.0004634382,0.000248479,0.00009654595,0.0006000088,0.00001617603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852828,0.004549204,0.000504146,0.0009976096,0.0006821811,0.002606864,0.00212316,0.0001140323,0.003139895],"genre_scores_gemma":[0.9884702,0.001453585,0.0009283103,0.001894269,0.0004428405,0.001817264,0.0015988,0.00002080392,0.003373952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006094141,"threshold_uncertainty_score":0.02038687,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.049249119791007,"score_gpt":0.3769303939944209,"score_spread":0.3276812742034139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}